Nucleus Biologics Bio-Expo Live February 2026: Upstream Bioprocessing

Cell and gene therapy developers face persistent challenges in media and buffer preparation, ranging from variability and scalability to cost and operational complexity. In this presentation, Nucleus Biologics introduces the Krakatoa® K500, the first bioreactor-scale, pod-based manufacturing system enabling on-demand, co-located media and buffer production. This system's closed, single-use design with real-time analytics creates digital batch records and delivers 35-500 liters of media within three hours.

Find out why early adopters are calling this innovation a fundamental reset in how the industry approaches media delivery and therapy cost structures.